105 related articles for article (PubMed ID: 29974200)
1. Metabolite profiling of the novel anti-cancer agent, plitidepsin, in urine and faeces in cancer patients after administration of
van Andel L; Rosing H; Tibben MM; Lucas L; Lubomirov R; Avilés P; Francesch A; Fudio S; Gebretensae A; Hillebrand MJX; Schellens JHM; Beijnen JH
Cancer Chemother Pharmacol; 2018 Sep; 82(3):441-455. PubMed ID: 29974200
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and excretion of
van Andel L; Fudio S; Rosing H; Munt S; Miguel-Lillo B; González I; Tibben MM; de Vries N; de Vries Schultink AHM; Schellens JHM; Beijnen JH
Invest New Drugs; 2017 Oct; 35(5):589-598. PubMed ID: 28111728
[TBL] [Abstract][Full Text] [Related]
3. Liquid chromatography-tandem mass spectrometry assay to quantify plitidepsin in human plasma, whole blood and urine.
van Andel L; Rosing H; Fudio S; Avilés P; Tibben MM; Gebretensae A; Schellens JHM; Beijnen JH
J Pharm Biomed Anal; 2017 Oct; 145():137-143. PubMed ID: 28662481
[TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution, metabolism, and excretion (ADME) of ¹⁴C-sonidegib (LDE225) in healthy volunteers.
Zollinger M; Lozac'h F; Hurh E; Emotte C; Bauly H; Swart P
Cancer Chemother Pharmacol; 2014 Jul; 74(1):63-75. PubMed ID: 24817600
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics meta-analysis of plitidepsin (Aplidin) in cancer subjects.
Nalda-Molina R; Valenzuela B; Ramon-Lopez A; Miguel-Lillo B; Soto-Matos A; Perez-Ruixo JJ
Cancer Chemother Pharmacol; 2009 Jun; 64(1):97-108. PubMed ID: 18941750
[TBL] [Abstract][Full Text] [Related]
6. Human mass balance study and metabolite profiling of
van Andel L; Zhang Z; Lu S; Kansra V; Agarwal S; Hughes L; Tibben MM; Gebretensae A; Lucas L; Hillebrand MJX; Rosing H; Schellens JHM; Beijnen JH
Invest New Drugs; 2017 Dec; 35(6):751-765. PubMed ID: 28303528
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and disposition of the anticancer quinolone derivative vosaroxin, a novel inhibitor of topoisomerase II.
Nijenhuis CM; Lucas L; Rosing H; Huitema ADR; Mergui-Roelvink M; Jamieson GC; Fox JA; Mould DR; Schellens JHM; Beijnen JH
Invest New Drugs; 2017 Aug; 35(4):478-490. PubMed ID: 28138829
[TBL] [Abstract][Full Text] [Related]
8. Mass balance, excretion and metabolism of [¹⁴C] ASA404 in cancer patients in a phase I trial.
McKeage MJ; Fong PC; Hong X; Flarakos J; Mangold J; Du Y; Tanaka C; Schran H
Cancer Chemother Pharmacol; 2012 May; 69(5):1145-54. PubMed ID: 22212299
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, metabolism, and excretion of (14)C-labeled belinostat in patients with recurrent or progressive malignancies.
Calvo E; Reddy G; Boni V; García-Cañamaque L; Song T; Tjornelund J; Choi MR; Allen LF
Invest New Drugs; 2016 Apr; 34(2):193-201. PubMed ID: 26769244
[TBL] [Abstract][Full Text] [Related]
10. Mass balance, metabolic disposition, and pharmacokinetics of a single oral dose of regorafenib in healthy human subjects.
Gerisch M; Hafner FT; Lang D; Radtke M; Diefenbach K; Cleton A; Lettieri J
Cancer Chemother Pharmacol; 2018 Jan; 81(1):195-206. PubMed ID: 29188322
[TBL] [Abstract][Full Text] [Related]
11. Metabolite profiling of bendamustine in urine of cancer patients after administration of [14C]bendamustine.
Dubbelman AC; Jansen RS; Rosing H; Darwish M; Hellriegel E; Robertson P; Schellens JH; Beijnen JH
Drug Metab Dispos; 2012 Jul; 40(7):1297-307. PubMed ID: 22492615
[TBL] [Abstract][Full Text] [Related]
12. Disposition, metabolism, and excretion of [14C]doripenem after a single 500-milligram intravenous infusion in healthy men.
Cirillo I; Mannens G; Janssen C; Vermeir M; Cuyckens F; Desai-Krieger D; Vaccaro N; Kao LM; Devineni D; Redman R; Turner K
Antimicrob Agents Chemother; 2008 Oct; 52(10):3478-83. PubMed ID: 18644951
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of trabectedin (ET-743, Yondelis) in patients with advanced cancer.
Beumer JH; Rademaker-Lakhai JM; Rosing H; Hillebrand MJ; Bosch TM; Lopez-Lazaro L; Schellens JH; Beijnen JH
Cancer Chemother Pharmacol; 2007 May; 59(6):825-37. PubMed ID: 16988825
[TBL] [Abstract][Full Text] [Related]
14. A phase I and pharmacokinetic study of plitidepsin in children with advanced solid tumours: an Innovative Therapies for Children with Cancer (ITCC) study.
Geoerger B; Estlin EJ; Aerts I; Kearns P; Gibson B; Corradini N; Doz F; Lardelli P; Miguel BD; Soto A; Prados R; Vassal G
Eur J Cancer; 2012 Feb; 48(3):289-96. PubMed ID: 22119199
[TBL] [Abstract][Full Text] [Related]
15. Single-dose pharmacokinetics of Nestorone, a potential female-contraceptive.
Prasad PV; Bashir M; Sitruk-Ware R; Kumar N
Steroids; 2010 Mar; 75(3):252-64. PubMed ID: 20064539
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and excretion of a novel p38 MAP kinase inhibitor pamapimod in healthy male subjects.
Zhang X; Fettner S; Winter E; Masjedizadeh M; Hisoire G
Int J Clin Pharmacol Ther; 2011 Jun; 49(6):345-52. PubMed ID: 21612741
[TBL] [Abstract][Full Text] [Related]
17. Metabolism, pharmacokinetics, and excretion of a nonpeptidic substance P receptor antagonist, ezlopitant, in normal healthy male volunteers: characterization of polar metabolites by chemical derivatization with dansyl chloride.
Prakash C; O'Donnell J; Khojasteh-Bakht SC
Drug Metab Dispos; 2007 Jul; 35(7):1071-80. PubMed ID: 17431029
[TBL] [Abstract][Full Text] [Related]
18. Phase I clinical and pharmacokinetic study of plitidepsin as a 1-hour weekly intravenous infusion in patients with advanced solid tumors.
Izquierdo MA; Bowman A; García M; Jodrell D; Martinez M; Pardo B; Gómez J; López-Martin JA; Jimeno J; Germá JR; Smyth JF
Clin Cancer Res; 2008 May; 14(10):3105-12. PubMed ID: 18483378
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
Prakash C; Kamel A; Gummerus J; Wilner K
Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
[TBL] [Abstract][Full Text] [Related]
20. Mass balance and pharmacokinetics of [14C]telavancin following intravenous administration to healthy male volunteers.
Shaw JP; Cheong J; Goldberg MR; Kitt MM
Antimicrob Agents Chemother; 2010 Aug; 54(8):3365-71. PubMed ID: 20516282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
